211At-YC-I-27

N/A

Report date: 2025/11/24 17:27:33

NME

Base Information

Drug Name211At-YC-I-27

Drug Alias NamePSMA-targeting alpha emitter (prostate tumor)211At-YC-I-27[211At]YC-I-27

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsRadionuclide imaging enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohns Hopkins University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A